Heterocyclic Compounds Commons^™

Dz-Bau2021-14n As Novel Pyrazolopyridine Nanocrystals: Appraisal Of Anticancer Activity Against Hct-116 And Ht-29 Colorectal Cancer Cell Lines, Zahra Kassem, Soumaiah Abou Staiteieh, Jamal Nasr, Amina Mneimneh, Ali Youssef, Nadine Darwiche, Doaa Issa, Raghida Bou Merhi, Mohammed Mehanna

BAU Journal - Health and Wellbeing

Mentioning DZ-BAU2021-14 (C₁₉H₁₇N₅O₂,347.370 g/mol) developed in BAU Labs, its promising preliminary antitumor effect nominated it to be selected as a lead antiproliferative compound against colorectal cancer cell lines owing to its proved Cyclin Dependent Kinase 2 (CDK2) inhibition (Kassem et al., 2021). Solving many problems restricting traditional cancer therapy, nanotechnology is offering safety margins and targeted delivery of poorly soluble drug. The potential effect of this compound was combined with the advantages of nanotechnology, precisely nanocrystals to achieve better antiproliferative and hopeful less cytotoxic patterns. The nanocrystals DZ-BAU2021-14N were …